Abbott’s Architect hepatitis B surface antigen (HBsAg) diagnostic test has been awarded the CE mark.

The HBsAg quantitative assay helps in the detection of acute and chronic Hepatitis B virus infections, and screens blood and blood products using the Architect immunochemistry system.

The test is a chemiluminescent microparticle immunoassay that enables clinicians to identify patients with low levels of HBsAg.

Biomnis biologist Thoai Duong Ly said that the Architect test helps to identify mutant strains of the Hepatitis B virus.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData